Alongside thyroid surveillance, individuals with a known or suspected germline DICER1 pathogenic mutation should be enrolled in lung and ovarian surveillance for detection of early PPB and SLCT, respectively, as DICER1 syndrome increases the risk of developing these tumours (67). This evidence concerns the gene DICER1 and neoplasm.